Vaidya Sane Ayurved Laboratories IPO vs Safa Systems IPO

Comparison between Vaidya Sane Ayurved Laboratories IPO and Safa Systems IPO.

IPO Details

Vaidya Sane Ayurved Laboratories IPO is a SME Fixed Price IPO proposed to list at NSE SME while Safa Systems IPO is a SME Fixed Price proposed to list at BSE SME.

Issue Size and Price

The total issue size of Vaidya Sane Ayurved Laboratories IPO is up to ₹19.20 Cr whereas the issue size of the Safa Systems IPO is up to ₹3.80 Cr. The final issue price of Vaidya Sane Ayurved Laboratories IPO is ₹73.00 per share and of Safa Systems IPO is ₹10.00 per share.

 Vaidya Sane Ayurved Laboratories IPOSafa Systems IPO
Face Value₹10 per share₹10 per share
Issue Price (Final)₹73.00 per share₹10.00 per share
Discount (Retail)₹0.00 per share₹0.00 per share
Market Lot Size1600 shares10000 shares
Fresh Issue Size26,30,400 shares38,00,000 shares
Fresh Issue Size (Amount)up to ₹19.20 Crup to ₹3.80 Cr
OFS Issue Size0 shares0 shares
OFS Issue Size (Amount)up to ₹0.00 Crup to ₹0.00 Cr
Issue Size Total26,30,400 shares38,00,000 shares
Issue Size Total (Amount)up to ₹19.20 Crup to ₹3.80 Cr

IPO Timetable

Vaidya Sane Ayurved Laboratories IPO opens on Feb 10, 2022, while Safa Systems IPO opens on Jan 28, 2022. The closing date of Vaidya Sane Ayurved Laboratories IPO and Safa Systems IPO is Feb 15, 2022, and Feb 01, 2022, respectively.

 Vaidya Sane Ayurved Laboratories IPOSafa Systems IPO
Issue OpenFeb 10, 2022Jan 28, 2022
Issue CloseFeb 15, 2022Feb 01, 2022
Basis Of Allotment (Tentative)Feb 18, 2022Feb 04, 2022
Initiation of Refunds (Tentative)Feb 21, 2022Feb 07, 2022
Credit of Share (Tentative)Feb 22, 2022Feb 08, 2022
Listing date (Tentative)Feb 23, 2022Feb 09, 2022

Financials & KPIs

Vaidya Sane Ayurved Laboratories IPO P/E ratio is 28.29, as compared to Safa Systems IPO P/E ratio of 29.41.

 Vaidya Sane Ayurved Laboratories IPOSafa Systems IPO
Financials

Company Financials (Restated)

Period Ended30 Sep 202131 Mar 202131 Mar 202031 Mar 2019
Assets25.7825.8129.1128.88
Total Income31.5752.2875.3062.57
Profit After Tax1.351.55-0.560.50
EBITDA2.614.632.713.04
NET Worth11.129.778.228.78
Reserves and Surplus4.159.728.178.74
Total Borrowing1.781.025.971.78
Amount in ₹ Crore

Company Financials (Restated)

Period Ended07 Oct 202131 Mar 202131 Mar 202031 Mar 2019
Assets44.6848.9340.2738.81
Total Income145.19208.66255.23255.74
Profit After Tax0.270.290.310.36
EBITDA1.672.333.202.26
NET Worth8.448.448.448.17
Total Borrowing29.2129.0025.5620.41
Amount in ₹ Crore
Promoter Shareholding (Pre-Issue)90.08%100%
Promoter Shareholding (Post-Issue)66.34%73.47%
P/E Ratio28.2929.41
Market Cap₹76.75 Cr.₹15.08 Cr.
EPS₹2.22
RoNW15.843.48

Shares Offered

In the Vaidya Sane Ayurved Laboratories IPO Retail Individual Investors (RII) are offered 13,15,200 shares while in Safa Systems IPO retail investors are offered 13,15,200 shares. Qualified Institutional Buyers (QIB) are offered in Vaidya Sane Ayurved Laboratories IPO and in Safa Systems IPO.

 Vaidya Sane Ayurved Laboratories IPOSafa Systems IPO
Market Maker Reservation1,40,800 shares2,00,000 shares
NII13,15,200 shares19,00,000 shares
RII13,15,200 shares19,00,000 shares
Total26,30,400 shares38,00,000 shares

Bids Received (Subscription)

Vaidya Sane Ayurved Laboratories IPO subscribed 2.82x in total, whereas Safa Systems IPO subscribed 52.71x.

Compare with others

Compare: